243 related articles for article (PubMed ID: 21189257)
1. PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.
Liu CY; Lv X; Li T; Xu Y; Zhou X; Zhao S; Xiong Y; Lei QY; Guan KL
J Biol Chem; 2011 Feb; 286(7):5558-66. PubMed ID: 21189257
[TBL] [Abstract][Full Text] [Related]
2. A cell-based screening for TAZ activators identifies ethacridine, a widely used antiseptic and abortifacient, as a compound that promotes dephosphorylation of TAZ and inhibits adipogenesis in C3H10T1/2 cells.
Kawano S; Maruyama J; Nagashima S; Inami K; Qiu W; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
J Biochem; 2015 Nov; 158(5):413-23. PubMed ID: 25979969
[TBL] [Abstract][Full Text] [Related]
3. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.
Liu CY; Zha ZY; Zhou X; Zhang H; Huang W; Zhao D; Li T; Chan SW; Lim CJ; Hong W; Zhao S; Xiong Y; Lei QY; Guan KL
J Biol Chem; 2010 Nov; 285(48):37159-69. PubMed ID: 20858893
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition.
Huang W; Lv X; Liu C; Zha Z; Zhang H; Jiang Y; Xiong Y; Lei QY; Guan KL
J Biol Chem; 2012 Jul; 287(31):26245-53. PubMed ID: 22692215
[TBL] [Abstract][Full Text] [Related]
5. Dephosphorylation of the transcriptional cofactor NACA by the PP1A phosphatase enhances cJUN transcriptional activity and osteoblast differentiation.
Addison WN; Pellicelli M; St-Arnaud R
J Biol Chem; 2019 May; 294(20):8184-8196. PubMed ID: 30948508
[TBL] [Abstract][Full Text] [Related]
6. PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction.
Lv XB; Liu CY; Wang Z; Sun YP; Xiong Y; Lei QY; Guan KL
EMBO Rep; 2015 Aug; 16(8):975-85. PubMed ID: 26116754
[TBL] [Abstract][Full Text] [Related]
7. PP1A-mediated dephosphorylation positively regulates YAP2 activity.
Wang P; Bai Y; Song B; Wang Y; Liu D; Lai Y; Bi X; Yuan Z
PLoS One; 2011; 6(9):e24288. PubMed ID: 21909427
[TBL] [Abstract][Full Text] [Related]
8. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
[TBL] [Abstract][Full Text] [Related]
9. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
[TBL] [Abstract][Full Text] [Related]
10. Histone Deacetylase Inhibitors Target the Leukemic Microenvironment by Enhancing a Nherf1-Protein Phosphatase 1α-TAZ Signaling Pathway in Osteoblasts.
Kremer KN; Dudakovic A; Hess AD; Smith BD; Karp JE; Kaufmann SH; Westendorf JJ; van Wijnen AJ; Hedin KE
J Biol Chem; 2015 Dec; 290(49):29478-92. PubMed ID: 26491017
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Phosphopeptide Positional Isomers on the Transcriptional Co-activator TAZ.
Roberto J; Sykes CE; Vacratsis PO
Biochemistry; 2020 Nov; 59(43):4148-4154. PubMed ID: 33086783
[TBL] [Abstract][Full Text] [Related]
12. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
13. The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ.
Habbig S; Bartram MP; Sägmüller JG; Griessmann A; Franke M; Müller RU; Schwarz R; Hoehne M; Bergmann C; Tessmer C; Reinhardt HC; Burst V; Benzing T; Schermer B
Hum Mol Genet; 2012 Dec; 21(26):5528-38. PubMed ID: 23026745
[TBL] [Abstract][Full Text] [Related]
14. AMOTL2 interaction with TAZ causes the inhibition of surfactant proteins expression in lung cells.
Lucci V; Di Palma T; D'Ambrosio C; Scaloni A; Zannini M
Gene; 2013 Oct; 529(2):300-6. PubMed ID: 23911299
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1.
Chen S; Kesler CT; Paschal BM; Balk SP
J Biol Chem; 2009 Sep; 284(38):25576-84. PubMed ID: 19622840
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory member of the apoptosis-stimulating proteins of the p53 family (iASPP) interacts with protein phosphatase 1 via a noncanonical binding motif.
Llanos S; Royer C; Lu M; Bergamaschi D; Lee WH; Lu X
J Biol Chem; 2011 Dec; 286(50):43039-44. PubMed ID: 21998301
[TBL] [Abstract][Full Text] [Related]
17. ASPP2 links the apical lateral polarity complex to the regulation of YAP activity in epithelial cells.
Royer C; Koch S; Qin X; Zak J; Buti L; Dudziec E; Zhong S; Ratnayaka I; Srinivas S; Lu X
PLoS One; 2014; 9(10):e111384. PubMed ID: 25360797
[TBL] [Abstract][Full Text] [Related]
18. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
19. The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.
Shanzer M; Ricardo-Lax I; Keshet R; Reuven N; Shaul Y
Oncogene; 2015 Aug; 34(32):4190-8. PubMed ID: 25362852
[TBL] [Abstract][Full Text] [Related]
20. Hippo signaling is intrinsically regulated during cell cycle progression by APC/C
Kim W; Cho YS; Wang X; Park O; Ma X; Kim H; Gan W; Jho EH; Cha B; Jeung YJ; Zhang L; Gao B; Wei W; Jiang J; Chung KS; Yang Y
Proc Natl Acad Sci U S A; 2019 May; 116(19):9423-9432. PubMed ID: 31000600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
